Abstract: The 0-1 Knapsack Problem (KP) and Bin Packing Problem (BPP) are NP-hard combinatorial optimization challenges often tackled using metaheuristics. Both problems have prominent utilization in ...

Octopath Traveler 0 is an ambitious game that even longtime fans of the series might need some time (and a few lost battles) to fully grasp the depth of the game's systems. Being based on Octopath ...

Dec 1 (Reuters) - The World Health Organization on Monday issued its first guideline on the use of GLP-1 therapies for obesity, conditionally recommending them as part of long-term treatment for the ...

To better understand which social media platforms Americans use, Pew Research Center surveyed 5,022 U.S. adults from Feb. 5 to June 18, 2025. SSRS conducted this National Public Opinion Reference ...

Escape from Tarkov's game director, Nikita Buyanov, admits on social media that the 1.0 Steam release version is "rough for sure," saying that the bug fixes from the pre-release version are "not ...

After a lengthy eight-year beta the Escape from Tarkov 1.0 release date is finally upon us, and after such a long wait, I'm here counting down the final hours with launch times carved up by region.

The number of people using injectable obesity treatments is increasing rapidly, and it is leading to declines in obesity, according to a new survey by the Gallup National Health and Well-Being Index.

July 31 (Reuters) - Infrastructure solutions provider Quanta Services (PWR.N), opens new tab raised its annual results forecast on Thursday and said it has acquired peer Dynamic Systems in a deal ...

Quanta Services (NYSE:PWR) said Thursday it agreed to acquire Dynamic Systems, one of the largest mechanical solutions providers in the U.S., for ~$1.35B, consisting of $1.15B in cash and $200M of ...

Why is this happening? Technology educator Avery Swartz told Canadian news outlet CTV News that she thinks women take less risks in the workplace because “statistically, they are more likely to be ...

AMSTERDAM — At the HLTH Europe 2025 conference, experts discussed the nuanced landscape of GLP-1 medications in Europe, revealing a complex interplay of skepticism, financial hurdles, and evolving ...